You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Colorcon
AstraZeneca
Mallinckrodt
McKesson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BARICITINIB

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Baricitinib

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01185353 A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Completed Incyte Corporation Phase 2 2010-10-01 The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
NCT01185353 A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy Completed Eli Lilly and Company Phase 2 2010-10-01 The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
NCT01683409 A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease Completed Incyte Corporation Phase 2 2012-08-01 This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Baricitinib

Condition Name

Condition Name for Baricitinib
Intervention Trials
Healthy Volunteers 10
Rheumatoid Arthritis 10
Atopic Dermatitis 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Baricitinib
Intervention Trials
Arthritis 14
Arthritis, Rheumatoid 11
Dermatitis 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Baricitinib

Trials by Country

Trials by Country for Baricitinib
Location Trials
United States 333
United Kingdom 56
Japan 53
Germany 45
Spain 33
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Baricitinib
Location Trials
Florida 18
California 18
Texas 17
Ohio 15
New York 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Baricitinib

Clinical Trial Phase

Clinical Trial Phase for Baricitinib
Clinical Trial Phase Trials
Phase 4 3
Phase 3 27
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Baricitinib
Clinical Trial Phase Trials
Not yet recruiting 26
Completed 18
Recruiting 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Baricitinib

Sponsor Name

Sponsor Name for Baricitinib
Sponsor Trials
Eli Lilly and Company 48
Incyte Corporation 17
National Cancer Institute (NCI) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Baricitinib
Sponsor Trials
Industry 66
Other 20
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
McKinsey
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.